Brain nicotinic acetylcholine receptors: native subtypes and their relevance

Trends in Pharmacological Sciences

Volumn 27, Issue 9, 2006, Pages 482-491

  Gotti, Cecilia ^a   Zoli, Michele ^b   Clementi, Francesco ^a  

^a CNR   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROTRANSMITTER; NICOTINIC AGENT; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; RECEPTOR SUBTYPE;

AGING; ALZHEIMER DISEASE; ANALGESIA; ATTENTION DEFICIT DISORDER; AUTISM; BINDING SITE; BRAIN REGION; COGNITION; DEPRESSION; EPILEPSY; HUMAN; LIGAND BINDING; MOTOR ACTIVITY; NEUROLOGIC DISEASE; NEUROTRANSMISSION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; RECEPTOR AFFINITY; RECEPTOR BINDING; REVIEW; REWARD; SCHIZOPHRENIA; TOBACCO DEPENDENCE;

ANIMALS; BINDING SITES; BRAIN; HUMANS; LIGANDS; PROTEIN SUBUNITS; RECEPTORS, NICOTINIC;

EID: 33747422892     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2006.07.004     Document Type: Review

References (88)

1. Hogg R.C., et al. Nicotinic acetylcholine receptors: from structure to brain function. Rev. Physiol. Biochem. Pharmacol. 147 (2003) 1-46
2. Gotti C., and Clementi F. Neuronal nicotinic receptors: from structure to pathology. Prog. Neurobiol. 74 (2004) 363-396
3. Dajas-Bailador F., and Wonnacott S. Nicotinic acetylcholine receptors and the regulation of neuronal signalling. Trends Pharmacol. Sci. 25 (2004) 317-324
4. Hogg R.C., and Bertrand D. Nicotinic acetylcholine receptors as drug targets. Curr. Drug Targets CNS Neurol. Disord. 3 (2004) 123-130
5. Picciotto M.R., and Zoli M. Nicotinic receptors in aging and dementia. J. Neurobiol. 53 (2002) 641-655
6. Wonnacott S. Presynaptic nicotinic ACh receptors. Trends Neurosci. 20 (1997) 92-98
7. Le Novere N., et al. The diversity of subunit composition in ChRs: evolutionary origins, physiologic and pharmacologic consequences. J. Neurobiol. 53 (2002) 447-456
8. Champtiaux N., and Changeux J.P. Knock-out and knock-in mice to investigate the role of nicotinic receptors in the central nervous system. Curr. Drug Targets CNS Neurol. Disord. 1 (2002) 319-330
9. Drago J., et al. Neuronal nicotinic receptors: insights gained from gene knockout and knockin mutant mice. Cell. Mol. Life Sci. 60 (2003) 1267-1280
10. Sher E., et al. Physiological roles of neuronal nicotinic receptor subtypes: new insights on the nicotinic modulation of neurotransmitter release, synaptic transmission and plasticity. Curr. Top. Med. Chem. 4 (2004) 283-297
11. Jensen A.A., et al. Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations. J. Med. Chem. 48 (2005) 4705-4745
12. Changeux J.P., and Edelstein S.J. Allosteric mechanisms of signal transduction. Science 308 (2005) 1424-1428
13. Celie P.H., et al. Nicotine and carbamylcholine binding to nicotinic acetylcholine receptors as studied in AChBP crystal structures. Neuron 41 (2004) 907-914
14. Celie P.H., et al. Crystal structure of acetylcholine-binding protein from Bulinus truncatus reveals the conserved structural scaffold and sites of variation in nicotinic acetylcholine receptors. J. Biol. Chem. 280 (2005) 26457-26466
15. Hansen S.B., et al. Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations. EMBO J. 24 (2005) 3635-3646
16. Corringer P.J., et al. Nicotinic receptors at the amino acid level. Annu. Rev. Pharmacol. Toxicol. 40 (2000) 431-458
17. Nelson M.E., et al. Alternate stoichiometries of α4β2 nicotinic acetylcholine receptors. Mol. Pharmacol. 63 (2003) 332-341
18. Lopez-Hernandez G.Y., et al. Nicotine-induced up-regulation and desensitization of α4β2 neuronal nicotinic receptors depend on subunit ratio. J. Biol. Chem. 279 (2004) 38007-38015
19. Moretti M., et al. Nicotinic acetylcholine receptor subtypes expression during rat retina development and their regulation by visual experience. Mol. Pharmacol. 66 (2004) 85-96
20. Le Novere N., et al. Neuronal nicotinic receptor α6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain. Eur. J. Neurosci. 8 (1996) 2428-2439
21. Azam L., et al. Expression of neuronal nicotinic acetylcholine receptor subunit mRNAs within midbrain dopamine neurons. J. Comp. Neurol. 444 (2002) 260-274
22. Klink R., et al. Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei. J. Neurosci. 21 (2001) 1452-1463
23. Whiteaker P., et al. Involvement of the α3 subunit in central nicotinic binding populations. J. Neurosci. 22 (2002) 2522-2529
24. Champtiaux N., et al. Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice. J. Neurosci. 23 (2003) 7820-7829
25. Jones I.W., and Wonnacott S. Why doesn't nicotinic ACh receptor immunoreactivity knock out?. Trends Neurosci. 28 (2005) 343-345
26. Maskos U., et al. Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors. Nature 436 (2005) 103-107
27. Zoli M., et al. Identification of four classes of brain nicotinic receptors using β2 mutant mice. J. Neurosci. 18 (1998) 4461-4472
28. Han Z.Y., et al. Localization of nAChR subunit mRNAs in the brain of Macaca mulatta. Eur. J. Neurosci. 12 (2000) 3664-3674
29. Lindstrom J. The structures of neuronal nicotinic receptors. In: Clementi F., et al. (Ed). Handbook of Experimental Pharmacology (2000), Springer 101-162
30. Severance E.G., and Cuevas J. Distribution and synaptic localization of nicotinic acetylcholine receptors containing a novel α7 subunit isoform in embryonic rat cortical neurons. Neurosci. Lett. 372 (2004) 104-109
31. Gotti C., et al. Expression of nigrostriatal α6-containing nicotinic acetylcholine receptors is selectively reduced, but not eliminated, by β3 subunit gene deletion. Mol. Pharmacol. 67 (2005) 2007-2015
32. Turner J.R., and Kellar K.J. Nicotinic cholinergic receptors in the rat cerebellum: multiple heteromeric subtypes. J. Neurosci. 25 (2005) 9258-9265
33. Picciotto M.R., et al. Neuronal nicotinic acetylcholine receptor subunit knockout mice: physiological and behavioral phenotypes and possible clinical implications. Pharmacol. Ther. 92 (2001) 89-108
34. Marritt A.M., et al. Nicotinic cholinergic receptors in the rat retina: simple and mixed heteromeric subtypes. Mol. Pharmacol. 68 (2005) 1656-1668
35. Zoli M., et al. Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum. J. Neurosci. 22 (2002) 8785-8789
36. Cui C., et al. The β3 nicotinic receptor subunit: a component of α-conotoxin MII-binding nicotinic acetylcholine receptors that modulate dopamine release and related behaviors. J. Neurosci. 23 (2003) 11045-11053
37. Gotti C., et al. Heterogeneity and selective targeting of neuronal nicotinic acetylcholine receptor (nAChR) subtypes expressed on retinal afferents of the superior colliculus and lateral geniculate nucleus: identification of a new native nAChR subtype α3β2 (α5 or β3) enriched in retinocollicular afferents. Mol. Pharmacol. 68 (2005) 1162-1171
38. Cartier G.E., et al. A new α-conotoxin which targets α3β2 nicotinic acetylcholine receptors. J. Biol. Chem. 271 (1996) 7522-7528
39. McIntosh J.M., et al. Analogs of α-conotoxin MII are selective for α6-containing nicotinic acetylcholine receptors. Mol. Pharmacol. 65 (2004) 944-952
40. Dowell C., et al. α-Conotoxin PIA is selective for α6 subunit-containing nicotinic acetylcholine receptors. J. Neurosci. 23 (2003) 8445-8452
41. Azam L., et al. α-Conotoxin BuIA, a novel peptide from Conus bullatus, distinguishes among neuronal nicotinic acetylcholine receptors. J. Biol. Chem. 280 (2005) 80-87
42. Barik J., and Wonnacott S. Indirect modulation by α7 nicotinic acetylcholine receptors of noradrenaline release in rat hippocampal slices: interaction with glutamate and GABA systems and effect of nicotine withdrawal. Mol. Pharmacol. 69 (2006) 618-628
43. Riganti L., et al. Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells. Br. J. Pharmacol. 146 (2005) 1096-1109
44. Clementi F., et al. Involvement of neuronal nicotinic receptors in disease. In: Clementi F., et al. (Ed). Handbook of Experimental Pharmacology (2000), Springer 751-778
45. Gotti, C. et al. Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimer's disease, Parkinson's disease and dementia with Lewy bodies by immunoprecipitation. Neurobiol. Dis. DOI:10.1016/j.nbd.2006.04.005 (www.sciencedirect.com)
46. Gotti C., et al. Brain neuronal nicotinic receptors as new targets for drug discovery. Curr. Pharm. Des. 12 (2006) 407-428
47. Cook L.J., et al. Candidate gene association studies of the α4 (CHRNA4) and β2 (CHRNB2) neuronal nicotinic acetylcholine receptor subunit genes in Alzheimer's disease. Neurosci. Lett. 358 (2004) 142-146
48. Ren X.Q., et al. Structural determinants of α4β2 nicotinic acetylcholine receptor trafficking. J. Neurosci. 25 (2005) 6676-6686
49. Sallette J., et al. Nicotine upregulates its own receptors through enhanced intracellular maturation. Neuron 46 (2005) 595-607
50. Kuryatov A., et al. Nicotine acts as a pharmacological chaperone to up-regulate human α4β2 acetylcholine receptors. Mol. Pharmacol. 68 (2005) 1839-1851
51. Quik M., et al. Subunit composition of nicotinic receptors in monkey striatum: effect of treatments with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine or l-DOPA. Mol. Pharmacol. 67 (2005) 32-41
52. Balestra B., et al. Chick optic lobe contains a developmentally regulated α2α5β2 nicotinic receptor subtype. Mol. Pharmacol. 58 (2000) 300-311
53. Conroy W.G., and Berg D.K. Nicotinic receptor subtypes in the developing chick brain: appearance of a species containing the α4, β2, and α5 gene products. Mol. Pharmacol. 53 (1998) 392-401
54. Hernandez S.C., et al. The nicotinic receptor in the rat pineal gland is an α3β4 subtype. Mol. Pharmacol. 66 (2004) 978-987
55. Barabino B., et al. An α4β4 nicotinic receptor subtype is present in chick retina: identification, characterization and pharmacological comparison with the transfected α4β4 and α6β4 subtypes. Mol. Pharmacol. 59 (2001) 1410-1417
56. Vailati S., et al. Developmental expression of heteromeric nicotinic receptor subtypes in chick retina. Mol. Pharmacol. 63 (2003) 1329-1337
57. Vailati S., et al. Functional α6-containing nicotinic receptors are present in chick retina. Mol. Pharmacol. 56 (1999) 11-19
58. Xiao Y., et al. Pharmacology of the agonist binding sites of rat neuronal nicotinic receptor subtypes expressed in HEK 293 cells. Bioorg. Med. Chem. Lett. 14 (2004) 1845-1848
59. Gotti C., et al. Pharmacology and biophysical properties of α7 and α7-α8 α-bungarotoxin receptor subtypes immunopurified from the chick optic lobe. Eur. J. Neurosci. 6 (1994) 1281-1291
60. Gotti C., et al. α7 and α8 nicotinic receptor subtypes immunopurified from chick retina have different immunological, pharmacological and functional properties. Eur. J. Neurosci. 9 (1997) 1201-1211
61. Gerzanich V., et al. Homomers of α8 and α7 subunits of nicotinic receptors exhibit similar channel but contrasting binding site properties. Mol. Pharmacol. 45 (1994) 212-220
62. 3H]d-aspartate release from rat frontal cortex in vitro. Neuropharmacology 49 (2005) 59-72
63. Loffler M., et al. Dopamine release in human neocortical slices: characterization of inhibitory autoreceptors and of nicotinic acetylcholine receptor-evoked release. Brain Res. Bull. 68 (2006) 361-373
64. 3H]dopamine release. Neuropharmacology 48 (2005) 72-79
65. 3H]dopamine release from hippocampus. J. Pharmacol. Exp. Ther. 312 (2005) 1298-1304
66. 3H]norepinephrine release from neonatal rat hypothalamus. Neuropharmacology 50 (2006) 81-88
67. 3H]dopamine release from synaptosomes prepared from four mouse brain regions. J. Pharmacol. Exp. Ther. 301 (2002) 651-660
68. Endo T., et al. Nicotinic acetylcholine receptor subtypes involved in facilitation of GABAergic inhibition in mouse superficial superior colliculus. J. Neurophysiol. 94 (2005) 3893-3902
69. Salminen O., et al. Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice. Mol. Pharmacol. 65 (2004) 1526-1535
70. Sanberg P.R., et al. Nicotine for the treatment of Tourette's syndrome. Pharmacol. Ther. 74 (1997) 21-25
71. Poirier M.F., et al. Prevalence of smoking in psychiatric patients. Prog. Neuropsychopharmacol. Biol. Psychiatry 26 (2002) 529-537
72. Martin-Ruiz C.M., et al. Molecular analysis of nicotinic receptor expression in autism. Brain Res. Mol. Brain Res. 123 (2004) 81-90
73. Lee M., et al. Nicotinic receptor abnormalities in the cerebellar cortex in autism. Brain 125 (2002) 1483-1495
74. Breese C.R., et al. Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia. Neuropsychopharmacology 23 (2000) 351-364
75. Leonard S., et al. Nicotinic receptor function in schizophrenia. Schizophr. Bull. 22 (1996) 431-445
76. Martin-Ruiz C.M., et al. Dementia rating and nicotinic receptor expression in the prefrontal cortex in schizophrenia. Biol. Psychiatry 54 (2003) 1222-1233
77. Levin E.D., et al. Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization. Psychopharmacology 184 (2006) 523-539
78. Newhouse P., et al. Nicotine and nicotinic receptor involvement in neuropsychiatric disorders. Curr. Top. Med. Chem. 4 (2004) 267-282
79. Shytle R.D., et al. Nicotinic acetylcholine receptors as targets for antidepressants. Mol. Psychiatry 7 (2002) 525-535
80. Shytle R.D., et al. Neuronal nicotinic receptor inhibition for treating mood disorders: preliminary controlled evidence with mecamylamine. Depress. Anxiety 16 (2002) 89-92
81. Quik M. Smoking, nicotine and Parkinson's disease. Trends Neurosci. 27 (2004) 561-568
82. Burghaus L., et al. Loss of nicotinic acetylcholine receptor subunits α4 and α7 in the cerebral cortex of Parkinson patients. Parkinsonism Relat. Disord. 9 (2003) 243-246
83. Kelton M.C., et al. The effects of nicotine on Parkinson's disease. Brain Cogn. 43 (2000) 274-282
84. Court J.A., et al. Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication. Neuroscience 98 (2000) 79-87
85. Court J., et al. Nicotinic receptor abnormalities in Alzheimer's disease. Biol. Psychiatry 49 (2001) 175-184
86. Perry E.K., et al. Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain. Am. J. Psychiatry 158 (2001) 1058-1066
87. Teaktong T., et al. Alzheimer's disease is associated with a selective increase in α7 nicotinic acetylcholine receptor immunoreactivity in astrocytes. Glia 41 (2003) 207-211
88. Gotti C., et al. Brain acetylcholine receptors. In: Giacobini E., and Pepeu G. (Eds). The Brain Cholinergic System (2006), Informa Healthcare 141-157